Gene · 6555
Papers1,442
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,442
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mulberry leaf flavonoids alleviate type 2 diabetes by remodeling the gut microbiota-bile acid axis and activating FXR signaling. | J Ethnopharmacol | 2027 | 42503322 | PubTator, text mining | PubMed |
| Proteomic profiling of drug and nutrient transporter expression by small intestinal region in neonates, pediatrics, and adults. | Drug Metab Dispos | 2026 | 42826635 | PubTator, text mining | PubMed |
| Correlated electron behavior and low-temperature magnetic anomalies in CeCo2Al8. | J Phys Condens Matter | 2026 | 42551485 | PubTator, text mining | PubMed |
| Structural insight into sodium-dependent bile acid transport by members of the SLC10 family. | Structure | 2026 | 42546690 | PubTator, text mining | PubMed |
| Parvovirus B19 infection as a trigger of acute cholestasis in heterozygous genetic BSEP deficiency: a case report and review of the literature of acute parvovirus B19-related hepatitis. | Intern Emerg Med | 2026 | 42496956 | PubTator, text mining | PubMed |
| Novel SLC10A2 variants induce primary bile acid malabsorption and dysbiosis with IBD-like features. | Inflamm Bowel Dis | 2026 | 42435330 | PubTator, text mining | PubMed |
| Targeted Ileal Bile Acid Transporter Inhibition as Rescue Therapy for Tirzepatide-Induced Severe Constipation: A Case Report. | Case Rep Gastroenterol | 2026 | 42421979 | PubTator, text mining | PubMed |
| Bile acids mediate liver-bone marrow crosstalk. | iScience | 2026 | 42389593 | PubTator, text mining | PubMed |
| Linerixibat: First Approval. | Drugs | 2026 | 42301363 | PubTator, text mining | PubMed |
| HSD3B1 links ileal steroid metabolism to bile acid regulation in patients with prostate cancer. | J Clin Invest | 2026 | 42294886 | PubTator, text mining | PubMed |
| New and emerging treatments for PBC-related pruritus. | Drugs Context | 2026 | 42232646 | PubTator, text mining | PubMed |
| Layered mixed-anion chalcohalides Pb4Sb4Q9Cl2 (Q = S, Se): puckered 2D frameworks, indirect band gaps, and low thermal conductivity. | Dalton Trans | 2026 | 42046950 | PubTator, text mining | PubMed |
| Chronic Diarrhoea in Children: The Role of SLC10A2 Gene in Primary Malabsorption of Biliary Acid. | Acta Paediatr | 2026 | 41964529 | PubTator, text mining | PubMed |
| Review Article: Ileal Bile Acid Transport (IBAT) Inhibitors as an Emerging Treatment for Cholestatic Liver Disease. | Aliment Pharmacol Ther | 2026 | 41953994 | PubTator, text mining | PubMed |
| Band Gap Tuneability in Antiperovskite-Based Nitrides AE3PnN and Imides AE5Pn2(NH)2 (AE = Ca, Sr; Pn = As, Sb, Bi). | Angew Chem Int Ed Engl | 2026 | 41919461 | PubTator, text mining | PubMed |
| Effect of octreotide-deoxycholate hydrophobic ion pairing solid dispersions on intestinal permeability to enhance octreotide absorption via increased lipophilicity and ASBT-mediated transport. | Int J Pharm | 2026 | 41905700 | PubTator, text mining | PubMed |
| Gut Microbiota-Bile Acid Axis in Type 2 Diabetes-Associated Gallbladder Diseases: Mechanisms and Therapeutic Potential. | Metabolites | 2026 | 41893361 | PubTator, text mining | PubMed |
| Upregulated beta-defensin-1 in murine and human biliary atresia associates with human native liver survival. | Sci Rep | 2026 | 41888359 | PubTator, text mining | PubMed |
| Impact of PFAS exposure on lipid metabolic pathways: mechanisms and implicatins in carcinogenesis. | Front Toxicol | 2026 | 41884325 | PubTator, text mining | PubMed |
| Odevixibat treatment for recurrent cholestasis in a patient with biallelic UNC45A variants causing osteo-oto-hepato-enteric syndrome. | JHEP Rep | 2026 | 41861679 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6555/papers